Correlation Between Akanda Corp and Evaxion Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akanda Corp and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akanda Corp and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akanda Corp and Evaxion Biotech AS, you can compare the effects of market volatilities on Akanda Corp and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akanda Corp with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akanda Corp and Evaxion Biotech.

Diversification Opportunities for Akanda Corp and Evaxion Biotech

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Akanda and Evaxion is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Akanda Corp and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and Akanda Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akanda Corp are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of Akanda Corp i.e., Akanda Corp and Evaxion Biotech go up and down completely randomly.

Pair Corralation between Akanda Corp and Evaxion Biotech

Given the investment horizon of 90 days Akanda Corp is expected to under-perform the Evaxion Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Akanda Corp is 1.03 times less risky than Evaxion Biotech. The stock trades about -0.08 of its potential returns per unit of risk. The Evaxion Biotech AS is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  767.00  in Evaxion Biotech AS on September 14, 2024 and sell it today you would lose (650.00) from holding Evaxion Biotech AS or give up 84.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Akanda Corp  vs.  Evaxion Biotech AS

 Performance 
       Timeline  
Akanda Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akanda Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Evaxion Biotech AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evaxion Biotech AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Akanda Corp and Evaxion Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akanda Corp and Evaxion Biotech

The main advantage of trading using opposite Akanda Corp and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akanda Corp position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.
The idea behind Akanda Corp and Evaxion Biotech AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments